Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care

Authors

Douglas W. Blayney

¹Stanford Cancer Institute, Stanford University, Stanford, CA

Douglas W. Blayney, Giovanni Bariani, Devika Das, Shaheenah Dawood, Michael Gnant, Roselle De Guzman, S. Eric Martin, Deirdre O'Mahony, Alex Roach, Paul Ruff, Carlos Sampaio, Jose Angel Sanchez, Verna Vanderpuye, Arif Kamal, Carolyn Hendricks

Preview

This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares perspectives from eight different countries, including Austria, Brazil, Ghana, Honduras, Ireland, the Philippines, South Africa, and the United Arab Emirates, which provide insight to their unique issues, challenges, and barriers to quality improvement in cancer care during the pandemic. These perspectives shed light on some key recommendations applicable on a global scale and focus on access to care, importance of expanding and developing new treatments for both COVID-19 and cancer, access to telemedicine, collecting and using COVID-19 and cancer registry data, establishing measures and guidelines to further enhance quality of care, and expanding communication among governments, health care systems, and health care providers. The impact of the COVID-19 pandemic on cancer care and quality improvement has been and will continue to be felt across the globe, but this report aims to share these experiences and learnings and to assist ASCO's international members and our global fight against the pandemic and cancer.